|
|
Other links at Articles > Hematology-Oncology |
| 2. |
Participants in Phase 1 Oncology Trials Not Vulnerable
|
|
|
Because phase I oncology trials offer relatively little clinical benefit but do carry with them the risk for serious harm, they have been cited as paradigmatic examples of research that exploits vulnerable people. Medscape Medical News
|
| 3. |
Cancer Survival Rates May Be Inherited
|
|
|
Second-generation patients with breast, lung, prostate, or colon cancer may face an increased risk for early mortality if their parents died within 10 years of their own cancer diagnosis. Medscape Medical News
|
|
|